Foldable synthetic molecules could infiltrate and bust apart the toxic protein clumps causing Parkinson’s
Researchers are finding ways to target the toxic proteins involved in neurodegenerative diseases such as Parkinson’s and Alzheimer’s that were once considered ‘undruggable.’
Current treatments for Parkinson's disease primarily focus on managing symptoms but do not address the underlying mechanisms causing the disease. Researchers have now developed a synthetic molecule called SK-129 that can prevent toxic protein clumps known as alpha-synuclein from forming and spreading within the brains of mice, thereby alleviating disease symptoms.
SK-129 functions by binding to specific areas of alpha-synuclein, effectively immobilizing the protein and hindering its tendency to clump together with other proteins. This synthetic molecule shows particular affinity for early-stage clumps, thus thwarting their growth and formation of new clumps.
The development of SK-129 and similar foldamers represents a significant advancement in the field of neurodegenerative diseases. Foldamers are laboratory-designed molecules that fold into stable, predictable shapes, enabling scientists to customize them to target specific biological entities. This adaptability is crucial, as many proteins implicated in neurodegenerative diseases, such as alpha-synuclein, have been deemed "undruggable" due to their flexibility and lack of well-defined binding sites for conventional drugs.
Foldamers' ability to engage difficult targets and disrupt abnormal protein interactions could open new treatment avenues not only for Parkinson's disease but also for other neurodegenerative disorders driven by toxic protein aggregation, including Alzheimer's disease and ALS. However, it is essential to note that the effectiveness and safety of SK-129 and similar foldamers have yet to be tested in human subjects, and further research is needed to optimize their long-term safety, determine optimal dosing, and understand their interaction with the human body.
Written by urgent.news from The Conversation's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
